These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 27390311

  • 1. Expressions of isopeptide bonds and corneodesmosin in middle ear cholesteatoma.
    Koizumi H, Kawaguchi R, Ohkubo JI, Ikezaki S, Kitamura T, Hohchi N, Hashida K, Suzuki H.
    Clin Otolaryngol; 2017 Apr; 42(2):252-262. PubMed ID: 27390311
    [Abstract] [Full Text] [Related]

  • 2. Expressions of TRPVs in the cholesteatoma epithelium.
    Do BH, Koizumi H, Ohbuchi T, Kawaguchi R, Suzuki H.
    Acta Otolaryngol; 2017 Oct; 137(10):1039-1045. PubMed ID: 28599589
    [Abstract] [Full Text] [Related]

  • 3. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S, Wang X, Ren H, Liu X, Ren J, Liu W.
    Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
    [Abstract] [Full Text] [Related]

  • 4. Complementary effect of hydroquinone and retinoic acid on corneocyte desquamation with their combination use.
    Cheong KA, Lee TR, Lee AY.
    J Dermatol Sci; 2017 Aug; 87(2):192-200. PubMed ID: 28433430
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
    Song JJ, Chae SW, Woo JS, Lee HM, Jung HH, Hwang SJ.
    Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
    [Abstract] [Full Text] [Related]

  • 6. Increased permeability of the epithelium of middle ear cholesteatoma.
    Koizumi H, Suzuki H, Ohbuchi T, Kitamura T, Hashida K, Nakamura M.
    Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
    [Abstract] [Full Text] [Related]

  • 7. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
    Thorup MB, Munk M, Poulsen SS, Gaihede M, Nexo E, Sorensen BS, Ovesen T.
    Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
    [Abstract] [Full Text] [Related]

  • 8. Differentiation characteristics of cholesteatoma epithelium determined by expression of transglutaminase isoenzymes.
    Chang CS, Jun BH, Song KY, Kim IG.
    J Korean Med Sci; 1999 Dec; 14(6):665-70. PubMed ID: 10642946
    [Abstract] [Full Text] [Related]

  • 9. Alterations in the desquamation-related proteolytic cleavage of corneodesmosin and other corneodesmosomal proteins in psoriatic lesional epidermis.
    Simon M, Tazi-Ahnini R, Jonca N, Caubet C, Cork MJ, Serre G.
    Br J Dermatol; 2008 Jul; 159(1):77-85. PubMed ID: 18460028
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
    McGovern JA, Meinert C, de Veer SJ, Hollier BG, Parker TJ, Upton Z.
    Br J Dermatol; 2017 Jan; 176(1):145-158. PubMed ID: 27442805
    [Abstract] [Full Text] [Related]

  • 12. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
    Hsu YC, Ho KY, Chai CY, Lee KW, Wang LF, Wu SC, Kuo WR, Tsai SM.
    Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ, Park JC, Bae CH, Song SY, Lee HM, Kim YD.
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [Abstract] [Full Text] [Related]

  • 14. Expressions of caspase-14 in human middle ear cholesteatoma.
    Jung MH, Lee JH, Cho JG, Jung HH, Hwang SJ, Chae SW.
    Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of placenta growth factor in human middle ear cholesteatoma.
    Cho JG, Lim HW, Woo JS, Hwang SJ, Lee HM, Chae SW.
    Acta Otolaryngol; 2006 Sep; 126(9):900-4. PubMed ID: 16864484
    [Abstract] [Full Text] [Related]

  • 16. [Epidermal growth factor in cholesteatoma--the second report: the localization in the horny layer].
    Goto Y.
    Nihon Jibiinkoka Gakkai Kaiho; 1990 Aug; 93(8):1192-9. PubMed ID: 2231169
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T, Kondo K, Yamasoba T, Suzuki M, Sugasawa M, Kaga K.
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
    Liu Y, Yu LL, Han J, Cheng JN, Yang DZ.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.